J&J psoriasis drug Stelara tames Crohn's disease in second trial

(Reuters) - Johnson & Johnson's Stelara psoriasis drug has shown effectiveness against Crohn's disease in a second late-stage trial, the company said on Friday, bolstering prospects of its approval for the additional use.

http://ift.tt/xePdMM

from Reuters: Health News
via animenewspro